Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Surgical Oncology > Pancreas > Flashcards

Pancreas Flashcards

1
Q

percent of pancreatic cancer eligible for resection

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Best prognostic subtype of PDAC

A

colloid carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Head v tail proportion of PDAC

A

65% head v 25% tail (rest is indeterminate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

possible cutaneous presentations of PDAC

A

Pemphigoid rash (cicatricial and bullous)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Imaging features of a PNET

A

highly vascular
early arterial enhancement
washout in the early portal phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sensitivity and specificity of CA 19-9

A

sensitivity 70 to 92%

Specificity 68 to 92%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Positive predictive value of CA19-9 in asymptomatic patient?

i.e. can we screen for PDAC with CA19-9

A

<1%

PMID 14731128

(no)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the utility of CA-19-9 to plan for surgery?

A

Do not use as indicator of operability (ASCO)

May become part of selection criteria for neoadjuvant therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When to biopsy prior to operating on PDAC?

A

Concern for:
chronic pancreatitis
autoimmune pancreatitis
(eg, extreme young age, prolonged ethanol abuse, history of other autoimmune diseases),

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

First-line biopsy procedure (if necessary) for PDAC?

A

EUS-guided FNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

NCCN unresectable definition for head PDAC

A
  • contact with SMA >180 degrees
  • contact with celiac axis >180 degrees
  • tumor contact with the first jejunal SMA branch
  • Unreconstructable SMV or portal vein
  • Contact with the most proximal draining jejunal branch into the SMV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

NCCN unresectable definition for tail PDAC

A
  • Solid tumor contact of >180 degrees with the SMA or celiac axis
  • Solid tumor contact with the celiac axis and aortic involvement
  • Unreconstructable SMV or portal vein due to tumor involvement or occlusion (thrombus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

NCCN borderline resectable definition for head PDAC

A

SMV or portal vein
>180 degrees contact with contour irregularity
or thrombosis of the vein.
inferior vena cava.
tumor contact
Solid tumor contact with the SMA ≤180 degrees.
Solid tumor contact with variable anatomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NCCN borderline resectable definition for tail PDAC

A
  • Solid tumor contact with the celiac axis of ≤180 degrees.
  • Solid tumor contact with the celiac axis >180 degrees without involvement of the aorta and withpreserved GDA, permitting an Appleby procedure (controverisal).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discrepancy between AJCC and “borderline resectable” PDAC in 7th edition AJCC

A

7th Ed AJCC uses T4 category to designate an unresectable primary tumor. However T4s (arterial involvement) are still resected with R0 margins at some centers, especially after neoadjuvant therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ability of CT scan to detect metastatic PDAC

A

Contrast-enhanced CT is the modality of choice to detect distant metastases (image 16). with ~90% sensitivity and specificity.

However, the sensitivity of CT for peritoneal dissemination not high to eliminate the need for diagnostic laparoscopy in equivocal cases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Role of Chest CT and PET in PDAC

A

Chest CT — most centers do not perform a routine staging chest CT for patients suspected of having pancreatic cancer because in the presence of lung metastases, the primary tumor is usually unresectable for another reason.

PET scanning — Studied, and probably not useful. In uncontrolled studies and meta-analyses, the sensitivity of integrated PET/CT (which has better spatial resolution as compared to PET alone) in the initial diagnosis of pancreatic cancer has ranged from 73 to 94 percent, while specificity ranges from 60 to 89 percent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Role of staging laparoscopy in PDAC?

A

Widespread acceptance, but no controlled studies demonstrate a benefit.

Some selectively perform for borderline tumors, CA19-9 >1000, and prior to neoadjuvant therapy.

Good idea to do to avoid giving RT to peritoneal disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Peritoneal cytology in PDAC?

A

Not routinely reccomended as most patients with positive cytology have additional features of unresectability.

[PMID 15055843 MEYERS paper]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

summary of resectability of PDAC

A

Remains controversial and somewhat of a continuum:
• nodal involvement beyond the peripancreatic tissues, and/or distant metastases.
•Direct involvement of the superior mesenteric artery (SMA), CHA, Celiac, by CT scan of low density tumor.
•Encasement or occlusion/thrombus of the superior mesenteric vein (SMV) or the SMV-portal vein

in practice, most of these patients are referred for neoadjuvant therapy prior to surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

T Staging of Pancreatic Cancer (PDAC and PNET)

A 
Primary tumor (T)
TX	Primary tumor cannot be assessed
T0	No evidence of primary tumor
Tis	Carcinoma in situ*
T1	< 2 cm or less in greatest dimension
T2	> 2 cm in greatest dimension
T3	Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery
T4	Tumor involves the celiac axis or the superior mesenteric artery (unresectable primary tumor)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Stage 0, IA, IB and IIA for PDAC (it’s simple!)

A 
Anatomic stage/prognostic groups
Stage 0	Tis	N0	M0
Stage IA	T1	N0	M0
Stage IB	T2	N0	M0
Stage IIA	T3	N0	M0
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

N Staging of Pancreatic Cancer

A

N0 or N1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What phase of CT scan is best for determining liver mets?

A

also occurs in the portal venous phase i.e. peak hepatic enhancement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Two Radiographic findings that should broaden your differential away from PDAC?

A

multifocal biliary strictures (autoimmune pancreatitis)

diffuse pancreatic ductal changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Sensitivity and Specificity of FNA for PDAC?

A

Sensitivity of 90%
specificity of 96%

K-ras and P53 molecular analysis are emerging as a non-routine test to improve sensitivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is an Appleby procedure?

A

Distal pancreatectomy with en-bloc resection of the celiac access.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

How is perfusion to the liver maintained after an Appleby procedure?

A

retrograde flow from SMA, up the GDA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the ARTERIAL PHASE of a triple contrast CT scan for PDAC?

A

The ARTERIAL PHASE of enhancement (first 30 seconds) opacifies celiac, SMA. Look for arterial involvement of tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What is the PANCREATIC PHASE of a triple contrast CT scan for PDAC?

A

The PANCREATIC PHASE Theoretically maximal attenuation difference between tumor and normal pancreas. Occurs between peak opacification of aorta and liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What is the PORTAL PHASE of a triple contrast CT scan for PDAC?

A

The PORTAL VENOUS PHASE, (1 min post-injection) provides enhancement of the superior mesenteric vein (SMV), splenic and portal veins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What is stage of positive peritoneal cytology for PDAC?

A

AJCC defines as M1 disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Stage IIB, III and IV for Pancreatic canacer

A 
Stage IIB	T1	N1	M0
               T2    N1    M0
               T3	N1	M0
Stage III	T4	Any N	M0
Stage IV	Any T	Any N	M1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

RECIST Complete Response

A

Disappearance of all target lesions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

RECIST Partial Response

A

> 30% decrease in the sum of the largest diameter of target lesions,

36
Q

RECIST Stable Disease

A

Neither sufficient shrinkage to qualify for PR (>30%) nor sufficient increase to qualify for PD (>20%), taking as reference the smallest sum largest diameter since the treatment started

37
Q

RECIST Progressive Disease

A

At least a 20% increase in the sum of the LD of target lesions, taking as reference the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions

38
Q

Differences in 5-year survival for PDAC based on nodes.

A

Five-year survival after margin-negative (R0) resection: 30% node-negative
10 % node-positive disease

39
Q

Stage IIB v Stage III pancreatic cancer 5-year OS

A

7.7% v 6.8%

Stage III is high risk for R1 resection; Stage IIB is any node positive.

40
Q

Two things to do before starting chemo-first treatment for PDAC

A

Tissue diagnosis is required!

Needs a stent since biliary obstruction will delay neoadjuvant chemo.

41
Q

Does BRCA status help select chemo for PDAC?

A

Not studied, but NCCN suggest consideration of gemcitabine plus cisplatin over FOLFIRINOX, for neoadjuvant chemo of PDAC that harbors a known BRCA mutation

42
Q

PDAC median survival OS R0 v R1?

What if RO is defined as >1mm margin?

A
  1. 6 v 16.5 months
  2. 7 v 17.1 months

PMID: 28692477

43
Q

What percent of R1 PDAC survive >10 years?

A

9%

PMID: 28692477

44
Q

What percent of R0 PDAC die before 2 years?

A

50%

PMID: 28692477

45
Q

What is the only perioperative management decision shown to change mortality following whipple?

A

Surgical drain placement in high risk patients

[Cameron JACS 2015; Van Buren Ann Surg 2014]

46
Q

Chemo for gallbladder cancer?

A

Gemcitabine/Cisplatin

47
Q

ABC-02 trial

A

ABC - Advanced Biliary Cancer

gem/cis v gem alone for metastatic biliary cancer.

11.7 months v 8.1 month survival

[Valle NEJM 2010]

48
Q

Hanging Maneuver

A

Anterior approach to liver resection without mobilization;

Sometimes necessary for large tumors.

49
Q

Glissonian approach

A

taking the portal triad outside the sheath, but intrahepatically.

50
Q

Low CEA, Low Mucin, Low Amylase in a pancreatic cyst

A

Serous cystadenoma

51
Q

pancreatic mass with uniform cells with large central nucleoli and eosinophilic granular cytoplasm

A

Pancreatic Acinar Cell Carcinoma

52
Q

Acinar Cell Carcinoma is what % of pancreatic tumors?

A

1%

53
Q

Defining presentation of Acinar Cell Carcinoma?

A

lipase secretion
arthralgia
eosinophilia
subcutaneous fat necrosis

54
Q

Mutations for Acinar Cell Carcinoma?

A

APC/beta-catenin pathway

55
Q

Median survival for Acinar Cell Carcinoma

A

30-60 months (better than PDAC)

56
Q

Adjuvant therapy for Acinar Cell Carcinoma

A

to rare to study, so same regimens as PDAC are used.

57
Q

What % of insulinomas have MEN I

A

5%

58
Q

What % of MEN I patients get insulinomas?

A

20%

59
Q

lab test work-up for insulinoma

A

insulin, pro-insulin and c-peptide

60
Q

Medical management of hypoglycemia from insulinoma?

A

diazoxide

61
Q

Contraindicated drug for insulinomas

A

octreotide (worsens hypoglycemia)

62
Q

pancreatic cystic lesion with fine septations and thin drainage

A

likely a serous cyst adenoma; radiographic observation is best option.

63
Q

four Ds of glucagonoma

A

diabetes
dermatitis
DVT
depression

64
Q

Treatment for necrolytic migratory erythema

glucagonoma dermatitis

A

intermittent infusions of amino acids

glucagonoma’s mess up gluconeogenesis

65
Q

high CEA and mucin/ viscous fluid in a pancreatic cyst

A

Mucinous cystic Neoplasm - resect

66
Q

biopsy finding for autoimmune pancreatitis

A

plasmacytic infiltration

67
Q

threshold for preoperative stenting of PDAC

A

bilirubin of 10 mg/dl or coagulopathy

68
Q

Does single agent chemotherapy palliate PDAC pain?

A

No

69
Q

Percent of PDAC that is genetic

A

20%

70
Q

Odds ratio for PDAC with hereditary pancreatitis?

A

50-80 fold higher than the general population

71
Q

Genetic disorder with highest risk of PDAC?

A

Peutz-Jeghers (STK11)

72
Q

Most common access for PVE

A

transhepatic contralateral approach

73
Q

argument against transhepatic contralateral approach to PVE

A

can injure the future liver remnant

74
Q

how long to wait after PVE to do volumetrics

A

4-8 weeks

75
Q

Do you need to stop chemo during PVE?

A

No

76
Q

Bleeding from the SMV splenic confluence, what to do?

A

apply pressure or stuff a raytec in the tunnel or both.

77
Q

resection criteria for hepatocellular adenomas?

A

> 5 cm in women

all in men

78
Q

central scar in liver lesion

A

Focal Nodular Hyperplasia

79
Q

How do you RFA lesion near a major liver vessel

A

Pringle while you RFA so as to prevent heat sink from blood flow.

80
Q

Favorable criteria for RFA of liver lesions (3)

A

tumors <3cm
away from liver surface
away from major inflow or outflow

81
Q

Pancreatic mass with low CEA, low amylase and periodic Acid Schiff positive globules

A

Solid pseudo-papillary tumor

82
Q

Treatment for Solid pseudo-papillary tumors of the pancreas?

A

resection

83
Q

Metastasectomy for Solid pseudo-papillary tumors of the pancreas?

A

Yes

84
Q

Candidacy for trials on liver transplantation for neuroendocrine mets

A

disease stability for 6 months

less than 50% of liver parenchyma involved

85
Q

metastasectomy for high grade PNET (> 20 mit/10 HPF)

A

no!

86
Q

Chemotherapy for high grade PNET?

A

yes! platinum/etoposide

87
Q

8th edition AJCC definition of T4 PDAC

A

8thEd AJCC staging system no longer classifies T4 disease as categorically unresectable. However, they do not use the term “borderline resectable” to classify any clinical stage of disease.

Surgical Oncology (23 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions